These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2035723)

  • 21. Haloperidol blood levels and clinical effects.
    Volavka J; Cooper T; Czobor P; Bitter I; Meisner M; Laska E; Gastanaga P; Krakowski M; Chou JC; Crowner M
    Arch Gen Psychiatry; 1992 May; 49(5):354-61. PubMed ID: 1586270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E; Svestka J
    Pharmacopsychiatry; 1993 Jul; 26(4):121-4. PubMed ID: 7694306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma haloperidol and clinical response: a role for reduced haloperidol in antipsychotic activity?
    Shostak M; Perel JM; Stiller RL; Wyman W; Curran S
    J Clin Psychopharmacol; 1987 Dec; 7(6):394-400. PubMed ID: 3429700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intramuscular haloperidol decanoate for neuroleptic maintenance therapy. Efficacy, dosage schedule and plasma levels. An open multicenter study.
    Deberdt R; Elens P; Berghmans W; Heykants J; Woestenborghs R; Driesens F; Reyntjens A; van Wijngaarden I
    Acta Psychiatr Scand; 1980 Oct; 62(4):356-63. PubMed ID: 7468294
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood levels of haloperidol in schizophrenic patients.
    Shvartsburd A; Dekirmenjian H; Smith RC
    J Clin Psychopharmacol; 1983 Feb; 3(1):7-12. PubMed ID: 6833528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind- evaluation of bromperidol versus haloperidol treatment in chronic psychotic patients.
    Malfroid M; Hens L; Roosen P; Dom R
    Acta Psychiatr Belg; 1978; 78(1):147-54. PubMed ID: 347877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine.
    Tate JL
    Am J Psychiatry; 1989 Mar; 146(3):399-400. PubMed ID: 2784039
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of route of administration on haloperidol plasma levels in psychotic patients.
    Bianchetti G; Zarifian E; Poirier-Littre MF; Morselli PL; Deniker P
    Int J Clin Pharmacol Ther Toxicol; 1980 Jul; 18(7):324-7. PubMed ID: 7429678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An open trial of buspirone added to neuroleptics in schizophrenic patients.
    Goff DC; Midha KK; Brotman AW; McCormick S; Waites M; Amico ET
    J Clin Psychopharmacol; 1991 Jun; 11(3):193-7. PubMed ID: 2066458
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic window of serum haloperidol concentration in acute schizophrenia and schizoaffective disorder.
    Ulrich S; Neuhof S; Braun V; Meyer FP
    Pharmacopsychiatry; 1998 Sep; 31(5):163-9. PubMed ID: 9832347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma/RBC haloperidol ratios and improvement in acute psychotic symptoms.
    Neborsky RJ; Janowsky DS; Perel JM; Munson E; Depry D
    J Clin Psychiatry; 1984 Jan; 45(1):10-3. PubMed ID: 6363395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Plasma monitoring of haloperidol. Correlation with clinical efficacy and plasma prolactin levels].
    Giraud-Serio J; Goyot C; Debray Q; Plaisant O; Grenier J; Pélicier Y
    Ann Med Psychol (Paris); 1985 Nov; 143(9):900-11. PubMed ID: 3834819
    [No Abstract]   [Full Text] [Related]  

  • 34. Lithium and haloperidol.
    Nemes ZC; Volavka J; Cooper TB; O'Donnell J; Jaeger J
    Biol Psychiatry; 1986 May; 21(5-6):568-9. PubMed ID: 3697447
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum concentrations of haloperidol pyridinium metabolites and the relationship with tardive dyskinesia and parkinsonism: a cross-section study in psychiatric patients.
    Ulrich S; Sandmann U; Genz A
    Pharmacopsychiatry; 2005 Jul; 38(4):171-7. PubMed ID: 16025420
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum haloperidol concentrations and clinical response in acute psychosis.
    Miller DD; Hershey LA; Duffy JP; Abernethy DR; Greenblatt DJ
    J Clin Psychopharmacol; 1984 Dec; 4(6):305-10. PubMed ID: 6511996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Haloperidol in psychiatry.
    Med Lett Drugs Ther; 1975 Jan; 17(3):11-2. PubMed ID: 1092991
    [No Abstract]   [Full Text] [Related]  

  • 38. Correlates of early neuroleptic response using a uniform haloperidol dose.
    Bowers MB; Swigar ME; Jatlow PI; Hoffman FJ; Goicoechea N
    Int Clin Psychopharmacol; 1987 Jul; 2(3):255-60. PubMed ID: 3693868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentrations of haloperidol and prolactin and clinical outcome in acutely psychotic patients.
    Aschauer HN; Schönbeck G; Langer G; Koinig G; Resch F; Hatzinger R; Chaudry HR; Sieghart W
    Pharmacopsychiatry; 1988 Sep; 21(5):246-51. PubMed ID: 3227055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
    Altamura AC; Buccio M; Colacurcio F; Colombo G; Terzi A
    Acta Neurol (Napoli); 1986 Feb; 8(1):19-26. PubMed ID: 3962752
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.